(R)-ETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE
Compound with spectra: 1 NMR
![(R)-ETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE](/api/compound/LQhBmMA7IRz.png?ph=true&h=300&w=458 "(R)-ETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE")
| SpectraBase Compound ID | LQhBmMA7IRz |
|---|---|
| InChI | InChI=1S/C13H18FN3O5/c1-4-22-12(20)10(7(2)3)15-9(18)6-17-5-8(14)11(19)16-13(17)21/h5,7,10H,4,6H2,1-3H3,(H,15,18)(H,16,19,21)/t10-/m1/s1 |
| InChIKey | MFPFAWFHLNIPFB-SNVBAGLBSA-N |
| Mol Weight | 315.3 g/mol |
| Molecular Formula | C13H18FN3O5 |
| Exact Mass | 315.123049 g/mol |
| Enantiomer InChIKey | MFPFAWFHLNIPFB-JTQLQIEISA-N |
| Racemate InChIKey | MFPFAWFHLNIPFB-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE
(2S,3S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-HYDROXYBUTANOATE
1-[(1',4',5',6'-Tetrahydro-4'-ethyl-2'-pyrimidinyl)methyl]-thymine - hydrochloride
1-[(1',4',5',6'-Tetrahydro-5',5'-dimethyl-2'-pyrimidinyl)methyl]-thymine - hydrochloride
1-[(4',5'-Dihydro-4',4'-dimethyl-3H-imidazol-2'-yl)methyl]-thymine - hydrochloride
1 -(3 -(4 -Aminobenzenesulfonamido) -3 -oxopropyl) -5 -fluoropyrimidine-2,4 -dione
(5-fluoro-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)methyl 1-adamantanecarboxylate
1-(3,4-Dehydrotetrahydro-2-furanyl)-5-fluorouracil
2-[(4-Chlorophenyl)methyl]amino-3-diethylamino-1-(2,4-dioxo-5-methylpyrimidin-1-yl)-propane
1-(3-benzoxy-1-methoxy-propyl)-5-fluoro-pyrimidine-2,4-quinone
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil | Molecules | 2009 |